As Associate Director of PD and CMC, Ping is responsible for collaboration with CDMO cross-functional teams, including Analytical Development, Manufacturing, and Quality, to establish processes and implement tech transfer for GMP production. Ping has over 15 years of experience in cell and gene therapy, with CMC expertise on lentiviral and AAV viral manufacture. Prior to Tevard, Ping held a senior manager position at Editas Med and senior scientist position at Wuxi Apptech.
